Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to support critical AI-driven drug discovery tasks, including Absci's advanced de novo antibody design models.
AMD will also invest $20 million in Absci through a PIPE (Private Investment in Public Equity), highlighting the increasing demand for innovative AI applications in drug discovery.
ABSI is currently trading at $3.28 or 6.8377% higher on the Nasdaq Global Select Market.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.